Luo, J.; Tan, G.; Thong, K.X.; Kafetzis, K.N.; Vallabh, N.; Sheridan, C.M.; Sato, Y.; Harashima, H.; Tagalakis, A.D.; Yu-Wai-Man, C.
Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery. Pharmaceutics 2022, 14, 2472.
https://doi.org/10.3390/pharmaceutics14112472
AMA Style
Luo J, Tan G, Thong KX, Kafetzis KN, Vallabh N, Sheridan CM, Sato Y, Harashima H, Tagalakis AD, Yu-Wai-Man C.
Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery. Pharmaceutics. 2022; 14(11):2472.
https://doi.org/10.3390/pharmaceutics14112472
Chicago/Turabian Style
Luo, Jinyuan, Greymi Tan, Kai Xin Thong, Konstantinos N. Kafetzis, Neeru Vallabh, Carl M. Sheridan, Yusuke Sato, Hideyoshi Harashima, Aristides D. Tagalakis, and Cynthia Yu-Wai-Man.
2022. "Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery" Pharmaceutics 14, no. 11: 2472.
https://doi.org/10.3390/pharmaceutics14112472
APA Style
Luo, J., Tan, G., Thong, K. X., Kafetzis, K. N., Vallabh, N., Sheridan, C. M., Sato, Y., Harashima, H., Tagalakis, A. D., & Yu-Wai-Man, C.
(2022). Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery. Pharmaceutics, 14(11), 2472.
https://doi.org/10.3390/pharmaceutics14112472
